Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Pharma & Healthcare

Published Date: 2026-01-04

Pages: 80 Pages

Report ld: 5557164

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Human Prothrombin Complex Market Size(US$)

CAGR 2026-2032

11.8%

Market Size,2032

USD 4,702

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 2,408 million

Market Forecast in 2032(Value)

US$ 4,702 million

CAGR

11.8%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Human Prothrombin Complex market size was US$ 2177 million in 2025 and is forecast to reach a readjusted size of US$ 4702 million by 2032 with a CAGR of 11.8% during the forecast period 2026-2032.

Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.

Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.

In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.

The global Human Prothrombin Complex market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.

MARKET SEGMENTATION

By Company

Takeda
CSL
Grifols
Octapharma
Hualan Biological
Meheco Xinxing Pharma

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others

Segment by Application

Hemophilia B
Vitamin K Deficiency
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term

Chapter 2: Quantitative analysis of Human Prothrombin Complex sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region

Chapter 3: Competitive landscape of Human Prothrombin Complex manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)

Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments

Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets

Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)

Chapter 7: Key manufacturer profiles –company overview, Human Prothrombin Complex product descriptions and specifications, revenue, gross margins, and recent developments

Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors

Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces

Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies

Chapter 11: Key findings, main takeaways, and overall conclusions of the report.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Human Prothrombin Complex value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Human Prothrombin Complex Product Scope

1.2 Human Prothrombin Complex by Type

1.2.1 Global Human Prothrombin Complex Sales by Type (2021, 2025 & 2032)

1.2.2 500 IU/Vial

1.2.3 600 IU/Vial

1.2.4 1000 IU/Vial

1.2.5 Others

1.3 Human Prothrombin Complex by Application

1.3.1 Global Human Prothrombin Complex Sales Comparison by Application (2021, 2025 & 2032)

1.3.2 Hemophilia B

1.3.3 Vitamin K Deficiency

1.3.4 Others

1.4 Global Human Prothrombin Complex Market Estimates and Forecasts (2021-2032)

1.4.1 Global Human Prothrombin Complex Market Size (Value) and Growth Rate (2021-2032)

1.4.2 Global Human Prothrombin Complex Market Size (Volume) and Growth Rate (2021-2032)

1.4.3 Global Human Prothrombin Complex Price Trends (2021-2032)

1.5 Assumptions and Limitations

2 Market Size and Prospects by Region

2.1 Global Human Prothrombin Complex Market Size by Region: 2021 VS 2025 VS 2032

2.2 Global Human Prothrombin Complex Historical Market Scenario by Region (2021-2026)

2.2.1 Global Human Prothrombin Complex Sales Market Share by Region (2021-2026)

2.2.2 Global Human Prothrombin Complex Revenue Market Share by Region (2021-2026)

2.3 Global Human Prothrombin Complex Market Estimates and Forecasts by Region (2027-2032)

2.3.1 Global Human Prothrombin Complex Sales Estimates and Forecasts by Region (2027-2032)

2.3.2 Global Human Prothrombin Complex Revenue Forecast by Region (2027-2032)

2.4 Major Regions and Emerging Market Analysis

2.4.1 North America Human Prothrombin Complex Market Size and Prospects (2021-2032)

2.4.2 Europe Human Prothrombin Complex Market Size and Prospects (2021-2032)

2.4.3 China Human Prothrombin Complex Market Size and Prospects (2021-2032)

2.4.4 Japan Human Prothrombin Complex Market Size and Prospects (2021-2032)

3 Global Market Size by Type

3.1 Global Human Prothrombin Complex Historical Market Review by Type (2021-2026)

3.1.1 Global Human Prothrombin Complex Sales by Type (2021-2026)

3.1.2 Global Human Prothrombin Complex Revenue by Type (2021-2026)

3.1.3 Global Human Prothrombin Complex Average Price by Type (2021-2026)

3.2 Global Human Prothrombin Complex Market Estimates and Forecasts by Type (2027-2032)

3.2.1 Global Human Prothrombin Complex Sales Forecast by Type (2027-2032)

3.2.2 Global Human Prothrombin Complex Revenue Forecast by Type (2027-2032)

3.2.3 Global Human Prothrombin Complex Price Forecast by Type (2027-2032)

3.3 Representative Players for Different Types of Human Prothrombin Complex

4 Global Market Size by Application

4.1 Global Human Prothrombin Complex Historical Market Review by Application (2021-2026)

4.1.1 Global Human Prothrombin Complex Sales by Application (2021-2026)

4.1.2 Global Human Prothrombin Complex Revenue by Application (2021-2026)

4.1.3 Global Human Prothrombin Complex Average Price by Application (2021-2026)

4.2 Global Human Prothrombin Complex Market Estimates and Forecasts by Application (2027-2032)

4.2.1 Global Human Prothrombin Complex Sales Forecast by Application (2027-2032)

4.2.2 Global Human Prothrombin Complex Revenue Forecast by Application (2027-2032)

4.2.3 Global Human Prothrombin Complex Price Forecast by Application (2027-2032)

4.3 New Sources of Growth in Human Prothrombin Complex Applications

5 Competition Landscape by Players

5.1 Global Human Prothrombin Complex Sales by Player (2021-2026)

5.2 Global Top Human Prothrombin Complex Players by Revenue (2021-2026)

5.3 Global Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Human Prothrombin Complex revenue as of 2025

5.4 Global Human Prothrombin Complex Average Price by Company (2021-2026)

5.5 Global Key Manufacturers of Human Prothrombin Complex, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Human Prothrombin Complex, Product Type & Application

5.7 Global Key Manufacturers of Human Prothrombin Complex, Date of Entry into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Regional Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Human Prothrombin Complex Sales by Company

6.1.1.1 North America Human Prothrombin Complex Sales by Company (2021-2026)

6.1.1.2 North America Human Prothrombin Complex Revenue by Company (2021-2026)

6.1.2 North America Human Prothrombin Complex Sales Breakdown by Type (2021-2026)

6.1.3 North America Human Prothrombin Complex Sales Breakdown by Application (2021-2026)

6.1.4 North America Human Prothrombin Complex Major Customers

6.1.5 North America Market Trends and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Human Prothrombin Complex Sales by Company

6.2.1.1 Europe Human Prothrombin Complex Sales by Company (2021-2026)

6.2.1.2 Europe Human Prothrombin Complex Revenue by Company (2021-2026)

6.2.2 Europe Human Prothrombin Complex Sales Breakdown by Type (2021-2026)

6.2.3 Europe Human Prothrombin Complex Sales Breakdown by Application (2021-2026)

6.2.4 Europe Human Prothrombin Complex Major Customers

6.2.5 Europe Market Trends and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Human Prothrombin Complex Sales by Company

6.3.1.1 China Human Prothrombin Complex Sales by Company (2021-2026)

6.3.1.2 China Human Prothrombin Complex Revenue by Company (2021-2026)

6.3.2 China Human Prothrombin Complex Sales Breakdown by Type (2021-2026)

6.3.3 China Human Prothrombin Complex Sales Breakdown by Application (2021-2026)

6.3.4 China Human Prothrombin Complex Major Customers

6.3.5 China Market Trends and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Human Prothrombin Complex Sales by Company

6.4.1.1 Japan Human Prothrombin Complex Sales by Company (2021-2026)

6.4.1.2 Japan Human Prothrombin Complex Revenue by Company (2021-2026)

6.4.2 Japan Human Prothrombin Complex Sales Breakdown by Type (2021-2026)

6.4.3 Japan Human Prothrombin Complex Sales Breakdown by Application (2021-2026)

6.4.4 Japan Human Prothrombin Complex Major Customers

6.4.5 Japan Market Trends and Opportunities

7 Company Profiles and Key Figures

7.1 Takeda

7.1.1 Takeda Company Information

7.1.2 Takeda Business Overview

7.1.3 Takeda Human Prothrombin Complex Sales, Revenue and Gross Margin (2021-2026)

7.1.4 Takeda Human Prothrombin Complex Products Offered

7.1.5 Takeda Recent Development

7.2 CSL

7.2.1 CSL Company Information

7.2.2 CSL Business Overview

7.2.3 CSL Human Prothrombin Complex Sales, Revenue and Gross Margin (2021-2026)

7.2.4 CSL Human Prothrombin Complex Products Offered

7.2.5 CSL Recent Development

7.3 Grifols

7.3.1 Grifols Company Information

7.3.2 Grifols Business Overview

7.3.3 Grifols Human Prothrombin Complex Sales, Revenue and Gross Margin (2021-2026)

7.3.4 Grifols Human Prothrombin Complex Products Offered

7.3.5 Grifols Recent Development

7.4 Octapharma

7.4.1 Octapharma Company Information

7.4.2 Octapharma Business Overview

7.4.3 Octapharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2021-2026)

7.4.4 Octapharma Human Prothrombin Complex Products Offered

7.4.5 Octapharma Recent Development

7.5 Hualan Biological

7.5.1 Hualan Biological Company Information

7.5.2 Hualan Biological Business Overview

7.5.3 Hualan Biological Human Prothrombin Complex Sales, Revenue and Gross Margin (2021-2026)

7.5.4 Hualan Biological Human Prothrombin Complex Products Offered

7.5.5 Hualan Biological Recent Development

7.6 Meheco Xinxing Pharma

7.6.1 Meheco Xinxing Pharma Company Information

7.6.2 Meheco Xinxing Pharma Business Overview

7.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2021-2026)

7.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Products Offered

7.6.5 Meheco Xinxing Pharma Recent Development

8 Human Prothrombin Complex Manufacturing Cost Analysis

8.1 Human Prothrombin Complex Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Human Prothrombin Complex

8.4 Human Prothrombin Complex Industrial Chain Analysis

9 Marketing Channels, Distributors and Customers

9.1 Marketing Channels

9.2 Human Prothrombin Complex Distributors List

9.3 Human Prothrombin Complex Customers

10 Human Prothrombin Complex Market Dynamics

10.1 Human Prothrombin Complex Industry Trends

10.2 Human Prothrombin Complex Market Drivers

10.3 Human Prothrombin Complex Market Challenges

10.4 Human Prothrombin Complex Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Human Prothrombin Complex Sales (US$ Million) Growth Rate by Type (2021, 2025 & 2032)

Table 2. Global Human Prothrombin Complex Sales (US$ Million) Comparison by Application (2021, 2025 & 2032)

Table 3. Global Market Human Prothrombin Complex Market Size (US$ Million) by Region:2021 VS 2025 VS 2032

Table 4. Global Human Prothrombin Complex Sales (K Units) by Region (2021-2026)

Table 5. Global Human Prothrombin Complex Sales Market Share by Region (2021-2026)

Table 6. Global Human Prothrombin Complex Revenue (US$ Million) Market Share by Region (2021-2026)

Table 7. Global Human Prothrombin Complex Revenue Share by Region (2021-2026)

Table 8. Global Human Prothrombin Complex Sales (K Units) Forecast by Region (2027-2032)

Table 9. Global Human Prothrombin Complex Sales Market Share Forecast by Region (2027-2032)

Table 10. Global Human Prothrombin Complex Revenue (US$ Million) Forecast by Region (2027-2032)

Table 11. Global Human Prothrombin Complex Revenue Share Forecast by Region (2027-2032)

Table 12. Global Human Prothrombin Complex Sales by Type (K Units) & (2021-2026)

Table 13. Global Human Prothrombin Complex Sales Share by Type (2021-2026)

Table 14. Global Human Prothrombin Complex Revenue by Type (US$ Million) & (2021-2026)

Table 15. Global Human Prothrombin Complex Average Price by Type (M USD/Unit) & (2021-2026)

Table 16. Global Human Prothrombin Complex Sales by Type (K Units) & (2027-2032)

Table 17. Global Human Prothrombin Complex Revenue by Type (US$ Million) & (2027-2032)

Table 18. Global Human Prothrombin Complex Average Price by Type (M USD/Unit) & (2027-2032)

Table 19. Representative Players of Each Type

Table 20. Global Human Prothrombin Complex Sales by Application (K Units) & (2021-2026)

Table 21. Global Human Prothrombin Complex Sales Share by Application (2021-2026)

Table 22. Global Human Prothrombin Complex Revenue by Application (US$ Million) & (2021-2026)

Table 23. Global Human Prothrombin Complex Average Price by Application (M USD/Unit) & (2021-2026)

Table 24. Global Human Prothrombin Complex Sales by Application (K Units) & (2027-2032)

Table 25. Global Human Prothrombin Complex Revenue Market Share by Application (US$ Million) & (2027-2032)

Table 26. Global Human Prothrombin Complex Average Price by Application (M USD/Unit) & (2027-2032)

Table 27. New Sources of Growth in Human Prothrombin Complex Applications

Table 28. Global Human Prothrombin Complex Sales by Company (K Units) & (2021-2026)

Table 29. Global Human Prothrombin Complex Sales Share by Company (2021-2026)

Table 30. Global Human Prothrombin Complex Revenue by Company (US$ Million) & (2021-2026)

Table 31. Global Human Prothrombin Complex Revenue Share by Company (2021-2026)

Table 32. Global Human Prothrombin Complex by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Prothrombin Complex as of 2025)

Table 33. Global Market Human Prothrombin Complex Average Price by Company (M USD/Unit) & (2021-2026)

Table 34. Global Key Manufacturers of Human Prothrombin Complex, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Human Prothrombin Complex, Product Type & Application

Table 36. Global Key Manufacturers of Human Prothrombin Complex, Date of Entry into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Human Prothrombin Complex Sales by Company (2021-2026) & (K Units)

Table 39. North America Human Prothrombin Complex Sales Market Share by Company (2021-2026)

Table 40. North America Human Prothrombin Complex Revenue by Company (2021-2026) & (US$ Million)

Table 41. North America Human Prothrombin Complex Revenue Market Share by Company (2021-2026)

Table 42. North America Human Prothrombin Complex Sales by Type (2021-2026) & (K Units)

Table 43. North America Human Prothrombin Complex Sales Market Share by Type (2021-2026)

Table 44. North America Human Prothrombin Complex Sales by Application (2021-2026) & (K Units)

Table 45. North America Human Prothrombin Complex Sales Market Share by Application (2021-2026)

Table 46. Europe Human Prothrombin Complex Sales by Company (2021-2026) & (K Units)

Table 47. Europe Human Prothrombin Complex Sales Market Share by Company (2021-2026)

Table 48. Europe Human Prothrombin Complex Revenue by Company (2021-2026) & (US$ Million)

Table 49. Europe Human Prothrombin Complex Revenue Market Share by Company (2021-2026)

Table 50. Europe Human Prothrombin Complex Sales by Type (2021-2026) & (K Units)

Table 51. Europe Human Prothrombin Complex Sales Market Share by Type (2021-2026)

Table 52. Europe Human Prothrombin Complex Sales by Application (2021-2026) & (K Units)

Table 53. Europe Human Prothrombin Complex Sales Market Share by Application (2021-2026)

Table 54. China Human Prothrombin Complex Sales by Company (2021-2026) & (K Units)

Table 55. China Human Prothrombin Complex Sales Market Share by Company (2021-2026)

Table 56. China Human Prothrombin Complex Revenue by Company (2021-2026) & (US$ Million)

Table 57. China Human Prothrombin Complex Revenue Market Share by Company (2021-2026)

Table 58. China Human Prothrombin Complex Sales by Type (2021-2026) & (K Units)

Table 59. China Human Prothrombin Complex Sales Market Share by Type (2021-2026)

Table 60. China Human Prothrombin Complex Sales by Application (2021-2026) & (K Units)

Table 61. China Human Prothrombin Complex Sales Market Share by Application (2021-2026)

Table 62. Japan Human Prothrombin Complex Sales by Company (2021-2026) & (K Units)

Table 63. Japan Human Prothrombin Complex Sales Market Share by Company (2021-2026)

Table 64. Japan Human Prothrombin Complex Revenue by Company (2021-2026) & (US$ Million)

Table 65. Japan Human Prothrombin Complex Revenue Market Share by Company (2021-2026)

Table 66. Japan Human Prothrombin Complex Sales by Type (2021-2026) & (K Units)

Table 67. Japan Human Prothrombin Complex Sales Market Share by Type (2021-2026)

Table 68. Japan Human Prothrombin Complex Sales by Application (2021-2026) & (K Units)

Table 69. Japan Human Prothrombin Complex Sales Market Share by Application (2021-2026)

Table 70. Takeda Company Information

Table 71. Takeda Description and Business Overview

Table 72. Takeda Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2021-2026)

Table 73. Takeda Human Prothrombin Complex Product

Table 74. Takeda Recent Development

Table 75. CSL Company Information

Table 76. CSL Description and Business Overview

Table 77. CSL Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2021-2026)

Table 78. CSL Human Prothrombin Complex Product

Table 79. CSL Recent Development

Table 80. Grifols Company Information

Table 81. Grifols Description and Business Overview

Table 82. Grifols Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2021-2026)

Table 83. Grifols Human Prothrombin Complex Product

Table 84. Grifols Recent Development

Table 85. Octapharma Company Information

Table 86. Octapharma Description and Business Overview

Table 87. Octapharma Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2021-2026)

Table 88. Octapharma Human Prothrombin Complex Product

Table 89. Octapharma Recent Development

Table 90. Hualan Biological Company Information

Table 91. Hualan Biological Description and Business Overview

Table 92. Hualan Biological Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2021-2026)

Table 93. Hualan Biological Human Prothrombin Complex Product

Table 94. Hualan Biological Recent Development

Table 95. Meheco Xinxing Pharma Company Information

Table 96. Meheco Xinxing Pharma Description and Business Overview

Table 97. Meheco Xinxing Pharma Human Prothrombin Complex Sales (K Units), Revenue (US$ Million), Price (M USD/Unit) and Gross Margin (2021-2026)

Table 98. Meheco Xinxing Pharma Human Prothrombin Complex Product

Table 99. Meheco Xinxing Pharma Recent Development

Table 100. Production Base and Market Concentration Rate of Raw Material

Table 101. Key Suppliers of Raw Materials

Table 102. Human Prothrombin Complex Distributors List

Table 103. Human Prothrombin Complex Customers List

Table 104. Human Prothrombin Complex Market Trends

Table 105. Human Prothrombin Complex Market Drivers

Table 106. Human Prothrombin Complex Market Challenges

Table 107. Human Prothrombin Complex Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

List of Figures

Figure 1. Human Prothrombin Complex Product Picture

Figure 2. Global Human Prothrombin Complex Sales (US$ Million) by Type (2021, 2025 & 2032)

Figure 3. Global Human Prothrombin Complex Sales Market Share by Type in 2025 & 2032

Figure 4. 500 IU/Vial Product Picture

Figure 5. 600 IU/Vial Product Picture

Figure 6. 1000 IU/Vial Product Picture

Figure 7. Others Product Picture

Figure 8. Global Human Prothrombin Complex Sales (US$ Million) by Application (2021, 2025 & 2032)

Figure 9. Global Human Prothrombin Complex Sales Market Share by Application in 2025 & 2032

Figure 10. Hemophilia B Examples

Figure 11. Vitamin K Deficiency Examples

Figure 12. Others Examples

Figure 13. Global Human Prothrombin Complex Sales, (US$ Million), 2021 VS 2025 VS 2032

Figure 14. Global Human Prothrombin Complex Sales Growth Rate (2021-2032) & (US$ Million)

Figure 15. Global Human Prothrombin Complex Sales (K Units) Growth Rate (2021-2032)

Figure 16. Global Human Prothrombin Complex Price Trends Growth Rate (2021-2032) & (M USD/Unit)

Figure 17. Human Prothrombin Complex Report Years Considered

Figure 18. Global Market Human Prothrombin Complex Market Size (US$ Million) by Region:2021 VS 2025 VS 2032

Figure 19. Global Human Prothrombin Complex Revenue Market Share by Region: 2021 VS 2025

Figure 20. North America Human Prothrombin Complex Revenue (US$ Million) Growth Rate (2021-2032)

Figure 21. North America Human Prothrombin Complex Sales (K Units) Growth Rate (2021-2032)

Figure 22. Europe Human Prothrombin Complex Revenue (US$ Million) Growth Rate (2021-2032)

Figure 23. Europe Human Prothrombin Complex Sales (K Units) Growth Rate (2021-2032)

Figure 24. China Human Prothrombin Complex Revenue (US$ Million) Growth Rate (2021-2032)

Figure 25. China Human Prothrombin Complex Sales (K Units) Growth Rate (2021-2032)

Figure 26. Japan Human Prothrombin Complex Revenue (US$ Million) Growth Rate (2021-2032)

Figure 27. Japan Human Prothrombin Complex Sales (K Units) Growth Rate (2021-2032)

Figure 28. Global Human Prothrombin Complex Revenue Share by Type (2021-2026)

Figure 29. Global Human Prothrombin Complex Sales Share by Type (2027-2032)

Figure 30. Global Human Prothrombin Complex Revenue Share by Type (2027-2032)

Figure 31. Global Human Prothrombin Complex Revenue Share by Application (2021-2026)

Figure 32. Global Human Prothrombin Complex Revenue Growth Rate by Application in 2021 & 2025

Figure 33. Global Human Prothrombin Complex Sales Share by Application (2027-2032)

Figure 34. Global Human Prothrombin Complex Revenue Share by Application (2027-2032)

Figure 35. Global Human Prothrombin Complex Sales Share by Company (2025)

Figure 36. Global Human Prothrombin Complex Revenue Share by Company (2025)

Figure 37. Global 5 Largest Human Prothrombin Complex Players Market Share by Revenue in Human Prothrombin Complex: 2021 & 2025

Figure 38. Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025

Figure 39. Manufacturing Cost Structure of Human Prothrombin Complex

Figure 40. Manufacturing Process Analysis of Human Prothrombin Complex

Figure 41. Human Prothrombin Complex Industrial Chain

Figure 42. Channels of Distribution (Direct Vs Distribution)

Figure 43. Distributors Profiles

Figure 44. Bottom-up and Top-down Approaches for This Report

Figure 45. Data Triangulation

Figure 46. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Human Prothrombin Complex in 2026? zhanKai

The global market size of Human Prothrombin Complex in 2026 was 2408 Million USD.

Which companies rank high in the global Human Prothrombin Complex market? shouQi

What is the annual compound growth rate of the global Human Prothrombin Complex market size from 2026 to 2032? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Human Prothrombin Complex in 2032? shouQi

Related Reports

Global Human Prothrombin Complex Market Research Report 2026
The global Human Prothrombin Complex market was valued at US$ 2177 million in 2025 and is anticipated to reach US$ 4702 million by 2032, at a CAGR of 11.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 117
USD 2900.00
(Single User License)
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Prothrombin Complex was estimated to be worth US$ 2177 million in 2025 and is projected to reach US$ 4702 million, growing at a CAGR of 11.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 100
USD 3950.00
(Single User License)
Global Human Prothrombin Complex Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Prothrombin Complex market is projected to grow from US$ 1968 million in 2024 to US$ 4251 million by 2031, at a CAGR of 11.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 146
USD 4900.00
(Single User License)
Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Human Prothrombin Complex was estimated to be worth US$ 1968 million and is forecast to reach approximately US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 139
USD 5900.00
(Single User License)
Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Prothrombin Complex market size was US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 80
USD 4250.00
(Single User License)
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Prothrombin Complex was estimated to be worth US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 100
USD 3950.00
(Single User License)
Global Human Prothrombin Complex Market Research Report 2025
The global market for Human Prothrombin Complex was valued at US$ 1968 million in the year 2024 and is projected to reach a revised size of US$ 4251 million by 2031, growing at a CAGR of 11.8% during the forecast period.
Published Date: 2025-01-16
Pages: 86
USD 2900.00
(Single User License)
Global Human Prothrombin Complex Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-17
Pages: 142
USD 5600.00
(Single User License)
Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-16
Pages: 137
USD 5900.00
(Single User License)
Global Human Prothrombin Complex Market Insights, Forecast to 2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-07
Pages: 90
USD 4900.00
(Single User License)

Global Human Prothrombin Complex Market Research Report 2026
The global Human Prothrombin Complex market was valued at US$ 2177 million in 2025 and is anticipated to reach US$ 4702 million by 2032, at a CAGR of 11.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 117
USD 2900.00 (Single User License)
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Prothrombin Complex was estimated to be worth US$ 2177 million in 2025 and is projected to reach US$ 4702 million, growing at a CAGR of 11.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 100
USD 3950.00 (Single User License)
Global Human Prothrombin Complex Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Prothrombin Complex market is projected to grow from US$ 1968 million in 2024 to US$ 4251 million by 2031, at a CAGR of 11.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 146
USD 4900.00 (Single User License)
Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Human Prothrombin Complex was estimated to be worth US$ 1968 million and is forecast to reach approximately US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 139
USD 5900.00 (Single User License)
Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Prothrombin Complex market size was US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 80
USD 4250.00 (Single User License)
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Prothrombin Complex was estimated to be worth US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 100
USD 3950.00 (Single User License)
Global Human Prothrombin Complex Market Research Report 2025
The global market for Human Prothrombin Complex was valued at US$ 1968 million in the year 2024 and is projected to reach a revised size of US$ 4251 million by 2031, growing at a CAGR of 11.8% during the forecast period.
Published: 2025-01-16
Pages: 86
USD 2900.00 (Single User License)
Global Human Prothrombin Complex Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-17
Pages: 142
USD 5600.00 (Single User License)
Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-16
Pages: 137
USD 5900.00 (Single User License)
Global Human Prothrombin Complex Market Insights, Forecast to 2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-07
Pages: 90
USD 4900.00 (Single User License)